NCT02384889View on ClinicalTrials.gov

DFMO in Children With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 7, 2019

Study Completion Date

January 6, 2020

Conditions
Type 1 Diabetes
Interventions
DRUG

Difluoromethylornithine

Active Therapy with DFMO

DRUG

Placebo

Placebo Comparitor

Trial Locations (3)

14222

Women and Children's Hospital of Buffalo, Buffalo

46202

Riley Hospital for Children, Indianapolis

53226

Children's Hospital of Wisconsin, Wauwatosa

All Listed Sponsors
lead

Indiana University

OTHER

NCT02384889 - DFMO in Children With Type 1 Diabetes | Biotech Hunter | Biotech Hunter